Cargando…
Do inflammasome impact COVID-19 severity?
COVID-19 pandemic has proven to be a dramatic challenge, introducing huge clinical differences that demand extensive investigations. Severe and critical patients may present coagulopathies and microthrombi, which results in varied complications, or acute respiratory distress syndrome that leads to f...
Autores principales: | Calado, Maria Beatriz, da Silva Santana, Crislayne Emilly, Crovella, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312707/ https://www.ncbi.nlm.nih.gov/pubmed/34337108 http://dx.doi.org/10.1007/s13337-021-00705-3 |
Ejemplares similares
-
Correction to: Do inflammasome impact COVID-19 severity?
por: Calado, Maria Beatriz, et al.
Publicado: (2021) -
Can Polymorphisms in NLRP3 Inflammasome Complex Be Associated with Postmenopausal Osteoporosis Severity?
por: Guaraná, Werbson Lima, et al.
Publicado: (2022) -
Inflammasome activation at the crux of severe COVID-19
por: Vora, Setu M., et al.
Publicado: (2021) -
Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
por: Bahadoram, Mohammad, et al.
Publicado: (2021) -
Severe COVID-19: NLRP3 Inflammasome Dysregulated
por: van den Berg, Daan F., et al.
Publicado: (2020)